Tatyana Golikova participated in the IV international forum of nature-like technologies at the Kurchatov Institute.
"Today, medical science is faced with the task of creating not only new medical technologies, but technologies that work together with the human body. Nature-like solutions in the field of healthcare are the way to personalized, gentle and truly caring medicine," said Tatiana Golikova.
The main thing about the development of nature-like technologies in Russia:.
Based on nature-like technologies, the first drug in gene therapy was created to treat Bechterev's disease.
Personalized natural-like medicines for the treatment of leukemia, lymphoma, cancer of the digestive and respiratory organs are used as part of mandatory health insurance.
Two drugs that teach the immune system to recognize tumor cells, intended for the treatment of melanoma in the skin and tumors in the digestive system, will become available in mandatory medical insurance next year.
In 2024, the first tissue engineering product was introduced for the treatment of knee joints using the patient's own cells. Starting in 2027, biomedical cell products will begin to be used for intestinal diseases, wounds and burns.
By the end of this year, the first biodegradable Russian screws will begin to be used to fuse bones during fractures. Such screws will not need to be removed during repeated operations.
One example of the use of nature-like technologies in the health field is nuclear medicine. Russia produces 60 radiopharmaceuticals used in cardiology, neurology, oncology and endocrinology.
"We already have a scientific and material base, strong scientific schools and working technologies. We will continue to develop our own developments, where nature will become our author in the creation of the technologies of the future," Tatiana Golikova noted.